Poland· PL-100090299
Euphyllin long
A theophylline product containing theophyllinum, registered in Poland by pharmaand GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Theophylline is registered in 12 of 19 countries.
Countries holding a registration under ATC R03DA04 (theophylline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Theophylline · ATC R03DA04
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of theophylline costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Theophylline · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- US United States$0.71 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Theophyllinum
- Manufacturer
- pharmaand GmbH
- Country
- Poland (PL)
- ATC code
- R03DA04
- ATC class
- Theophylline
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990450213
- gtin05909990450220
- gtin05909990450237
- gtin09120099670111
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
438 interactions on record for theophylline.
Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Theophylline · interactions on record
438 records
- 34 severe
- 222 moderate
- 45 minor
- 132 info
Most severe, free to view
- MexiletineC01BB02severe
- RiociguatC02KX05severe
- PindololC07AA03severe
- PropranololC07AA05severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Theophylline in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEUPHYLLIN CR NAstraZeneca AB, Södertälje
- FinlandXanthiumHexal AG
- BelgiumXanthium 300 300 mgLaboratoires S.M.B.
- United KingdomTheo-24 300mg modified-release capsulesImported (United States)
- NorwayEuphyllin CRPharmaand
- United StatesTheo-24ENDO USA, Inc.
- FranceDILATRANE 300 mg, gélule à libération prolongéeSERP
- Japanテオフィリン
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Theospirex, Theospirex Retard
- Belgium · Xanthium
- Bulgaria · Теотард
- Cyprus · Theo-Dur
- Czechia · Euphyllin Cr N
- Germany · Afpred Forte-Theo, Bronchoretard
- Denmark · Theo-Dur, Unixan
- Estonia · Teotard
- Spain · Elixifilin, Teromol Retard
- Finland · Retafyllin
- France · Dilatrane, Tedralan
- United Kingdom (Northern Ireland) · Uniphyllin
- Greece · Theo-Bros, Theo-Dur
- Croatia · Teotard
- Hungary · Theophyllini Fono Vii. Naturland, Theophyllini Fono Viii. Parma
- Ireland · Uniphyllin
- Lithuania · Teotard
- Luxembourg · Xanthium
- Latvia · Teotard
- Norway · Theo-Dur
- Portugal · Unicontin
- Romania · Teotard
- Sweden · Theo-Dur
- Slovenia · Teotard
- Slovakia · Euphyllin Cr N 200, Euphyllin Cr N 300
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6d04a9f-8478-44f3-adf5-376bfe8b9a41 GET /v1/drugs/e6d04a9f-8478-44f3-adf5-376bfe8b9a41?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki o zmodyfikowanym uwalnianiu, twarde",
"source": "urpl",
"strength": "300 mg",
"packaging": "05909990450213 ¦ Rp ¦ Skasowane ¦ 13641\n30 kaps.\n05909990450220 ¦ Rp ¦ 15477\n20 kaps.\n05909990450237 ¦ Rp ¦ 44105\n100 kaps.\n09120099670111 ¦ Rp ¦ 142283\n30 kaps.",
"substance": "Theophyllinum 300 mg",
"common_name": "Theophyllinum",
"pl_product_id": "100090299",
"pozwolenie_nr": "04502",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about theophylline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.